Metastatic pheochromocytoma/paraganglioma related to primary tumor development in childhood or adolescence: Significant link to SDHB mutations

Journal of Clinical Oncology

Volumn 29, Issue 31, 2011, Pages 4137-4142

  King, Kathryn S ^a   Prodanov, Tamara ^a   Kantorovich, Vitaly ^d   Fojo, Tito ^b   Hewitt, Jacqueline K ^e   Zacharin, Margaret ^e   Wesley, Robert ^c   Lodish, Maya ^a   Raygada, Margarita ^a   Gimenez Roqueplo, Anne Paule ^f,g   McCormack, Shana ^h   Eisenhofer, Graeme ⁱ   Milosevic, Dragana ^j   Kebebew, Electron ^b   Stratakis, Constantine A ^a   Pacak, Karel ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h BOSTON CHILDREN S HOSPITAL   (United States)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE B; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; OUTCOME ASSESSMENT; PHEOCHROMOCYTOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR GROWTH; TUMOR LOCALIZATION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PREDICTIVE VALUE OF TESTS; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 80755127100     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.6353     Document Type: Article

References (29)

1. Hao HX, Khalimonchuk O, Schraders M, et al.: SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139-1142, 2009
2. Bayley JP, Kunst HP, Cascon A, et al.: SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol 11:366-372, 2010
3. Qin Y, Yao L, King EE, et al.: Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet 42:229-233, 2010
4. Burnichon N, Brière JJ, Libé R, et al.: SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19:3011-3020, 2010
5. Baysal BE, Ferrell RE, Willett-Brozick JE, et al.: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848-851, 2000 (Pubitemid 30084326)
6. Niemann S, Müller U: Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268-270, 2000
7. Astuti D, Latif F, Dallol A, et al.: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49-54, 2001 (Pubitemid 32614017)
8. Barontini M, Levin G, Sanso G: Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci 1073:30-37, 2006 (Pubitemid 44911995)
9. Stackpole RH, Melicow MM, Uson AC: Pheochromocytoma in children. Report of 9 case and review of the first 100 published cases with follow-up studies. J Pediatr 63:314-330, 1963
10. Ross JH: Pheochromocytoma. Special considerations in children. Urol Clin North Am 27:393-402, 2000
11. Pham TH, Moir C, Thompson GB, et al.: Pheochromocytoma and paraganglioma in children: A review of medical and surgical management at a tertiary care center. Pediatrics 118:1109-1117, 2006 (Pubitemid 46090053)
12. Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459-1466, 2002 (Pubitemid 34755714)
13. Linnoila RI, Keiser HR, Steinberg SM, et al.: Histopathology of benign versus malignant sympathoadrenal paragangliomas: Clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21:1168-1180, 1990 (Pubitemid 20382001)
14. Waguespack SG, Rich T, Grubbs E, et al.: A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95:2023-2037, 2010
15. Reference deleted
16. Timmers HJ, Kozupa A, Eisenhofer G, et al.: Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 92:779-786, 2007 (Pubitemid 46465640)
17. Brouwers FM, Eisenhofer G, Tao JJ, et al.: High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: Implications for genetic testing. J Clin Endocrinol Metab 91:4505-4509, 2006 (Pubitemid 44833431)
18. Favier J, Brière JJ, Burnichon N, et al.: The Warburg effect is genetically determined in inherited pheochromocytomas. PLoS One 4:e7094, 2009
19. Favier J, Gimenez-Roqueplo AP: Pheochromocytomas: The (pseudo)-hypoxia hypothesis. Best Pract Res Clin Endocrinol Metab 24:957-968, 2010
20. Liu Q, Liu R, Kashyap MV, et al.: Brainstem glioma progression in juvenile and adult rats. J Neurosurg 109:849-855, 2008
21. Eisenhofer G, Goldstein DS, Sullivan P, et al.: Biochemical and clinical manifestations of dopamineproducing paragangliomas: Utility of plasma methoxytyramine. J Clin Endocrinol Metab 90:2068-2075, 2005 (Pubitemid 40586241)
22. Florkowski CM, Fairlamb DJ, Freeth MG, et al.: Raised dopamine metabolites in a case of malignant paraganglioma. Postgrad Med J 66:471-473, 1990 (Pubitemid 20187967)
23. Azzarelli B, Felten S, Muller J, et al.: Dopamine in paragangliomas of the glomus jugulare. Laryngoscope 98:573-578, 1988
24. Eisenhofer G, Lenders JW, Timmers H, et al.: Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 57:411-420, 2011
25. Burnichon N, Rohmer V, Amar L, et al.: The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 94:2817-2827, 2009
26. Timmers HJ, Kozupa A, Chen CC, et al.: Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 25:2262-2269, 2007 (Pubitemid 46954653)
27. Moore SW, Appfelstaedt J, Zaahl MG: Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2. J Pediatr Surg 42:326-332, 2007 (Pubitemid 46161553)
28. American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, et al.: Medullary thyroid cancer: Management guidelines of the American Thyroid Association. Thyroid 19:565-612, 2009
29. Janeway KA, Kim SY, Lodish M, et al.: Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A 108:314-318, 2011